2.48
Precedente Chiudi:
$2.51
Aprire:
$2.56
Volume 24 ore:
457.74K
Relative Volume:
1.17
Capitalizzazione di mercato:
$51.37M
Reddito:
-
Utile/perdita netta:
$-16.51M
Rapporto P/E:
-1.8332
EPS:
-1.3528
Flusso di cassa netto:
$-15.68M
1 W Prestazione:
-2.36%
1M Prestazione:
+22.17%
6M Prestazione:
-25.97%
1 anno Prestazione:
+0.00%
Medicus Pharma Ltd Stock (MDCX) Company Profile
Nome
Medicus Pharma Ltd
Settore
Industria
Telefono
610-540-7515
Indirizzo
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Confronta MDCX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MDCX
Medicus Pharma Ltd
|
2.48 | 51.37M | 0 | -16.51M | -15.68M | -1.3528 |
![]()
LLY
Lilly Eli Co
|
833.49 | 766.78B | 53.26B | 13.80B | -50.20M | 15.08 |
![]()
JNJ
Johnson Johnson
|
190.72 | 460.19B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
230.50 | 407.53B | 58.33B | 3.73B | 18.24B | 2.1013 |
![]()
NVS
Novartis Ag Adr
|
130.03 | 253.71B | 53.40B | 13.68B | 16.89B | 6.8864 |
![]()
MRK
Merck Co Inc
|
85.99 | 218.56B | 63.43B | 16.42B | 14.72B | 6.4861 |
Medicus Pharma Ltd Borsa (MDCX) Ultime notizie
Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing - Cheboygan Daily Tribune
Is this a good reentry point in Medicus Pharma Ltd.Weekly Market Report & Low Risk Entry Point Guides - newser.com
Medicus Pharma Ltd. To Present at Brookline Capital Markets - Lansing State Journal
Medicus Pharma to acquire Antev - MSN
Using portfolio simulators with Medicus Pharma Ltd. includedJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Price action breakdown for Medicus Pharma Ltd.Earnings Summary Report & Daily Momentum Trading Reports - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock affected by interest rate hikesWeekly Profit Summary & Daily Chart Pattern Signals - newser.com
Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology - openPR.com
Oklahoma City NewsThe Oklahoman - FinancialContent
Key metrics from Medicus Pharma Ltd.’s quarterly dataDollar Strength & Community Driven Trade Alerts - newser.com
Should you hold or exit Medicus Pharma Ltd. now2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
Measuring Medicus Pharma Ltd. Equity Warrant’s beta against major indices2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com
Using economic indicators to assess Medicus Pharma Ltd. potential2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
How Medicus Pharma Ltd. (N460) stock reacts to Fed tighteningOil Prices & Low Drawdown Investment Strategies - newser.com
Measuring Medicus Pharma Ltd.’s beta against major indicesJuly 2025 Volume & Free Community Consensus Stock Picks - newser.com
How Medicus Pharma Ltd. (N460) stock trades in high volatilityMarket Trend Summary & Reliable Momentum Entry Alerts - newser.com
Is Medicus Pharma Ltd. (N460) stock a momentum leaderTake Profit & Verified Momentum Stock Ideas - newser.com
What analysts say about Medicus Pharma Ltd stockProtective Put Strategies & Free Robust Financial Gains - earlytimes.in
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE - Amarillo Globe-News
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject - Pueblo Chieftain
How currency fluctuations impact Medicus Pharma Ltd. Equity Warrant stockWeekly Profit Report & Proven Capital Preservation Methods - newser.com
Real time pattern detection on Medicus Pharma Ltd. stockDip Buying & Stock Portfolio Risk Management - newser.com
Relative strength of Medicus Pharma Ltd. Equity Warrant in sector analysis2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com
Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Medicus Pharma Ltd Azioni (MDCX) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
VELOCITY FUND PARTNERS, LP | 10% Owner |
May 20 '25 |
Sale |
7.72 |
75,000 |
578,940 |
3,248,741 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):